Chemotherapy for Breast Cancer

Follow the links below to find information on chemotherapy for breast cancer.

Reviewed July 2009

Printer friendly page

Related HealthInsite Topics

Systematic Reviews of Chemotherapy for Breast Cancer
HealthInsite Topic Page
Links to systematic reviews of the evidence for the effectiveness of chemotherapy for breast cancer.

9 Resources Found
Results 1 to 9 displayed.

Title:   Breast cancer
Publisher:   The Jean Hailes Foundation for Women's Health
Description:   Women who develop breast cancer may be at risk of osteoporosis.
Date:   Jul 2009

Title:   Chemotherapy
Publisher:   National Breast and Ovarian Cancer Centre
Description:   Chemotherapy for early breast cancer uses drugs to destroy any cancer cells that may have spread outside the breast and armpit area to other parts of the body or are left in the breast and armpit area but cannot be detected.
Date:   Jul 2009

Title:   Side effects of chemotherapy
Publisher:   National Breast and Ovarian Cancer Centre
Description:   Because the drugs all work differently, they have different side effects. Chemotherapy drugs can also affect individual women in different ways. Most side effects of chemotherapy can be managed with medical care. Side effects can include nausea, vomiting, fatigue, tiredness, hair loss, diarrhoea, constipation, weight gain, weight loss, depression, anxiety, menopausal symptoms, sexual difficulties, mouth ulcers and infections, skin changes, nail changes, nerve, muscle problems, swelling, feeling vague, in a fog, infection, bleeding, bruising, kidney problems, bladder problems, heart problems, bone marrow problems, allergic reactions.
Date:   Jul 2009

Title:   What does chemotherapy involve?
Publisher:   National Breast and Ovarian Cancer Centre
Description:   Before starting chemotherapy treatment, the woman will meet with a medical oncologist to discuss which types of chemotherapy are recommended and the side effects of these treatments.
Date:   Jul 2009

Title:   Recommedations for use of Taxane-containing chemotherapy regimens for the treatment of early (operable) breast cancer
Publisher:   National Breast and Ovarian Cancer Centre (NBOCC)
Description:   A clinical practice guideline developed by NBOCC. This document supplements systemic adjuvant therapy guideline recommendations 12-22 (pp 8-10), specially those about chemotherapy regimens contained in the Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001
Date:   May 2009

Title:   PBAC: taxanes
Publisher:   Australian Prescriber
Description:   The listing of trastuzumab on the Pharmaceutical Benefits Scheme (PBS) in October 2006 was heralded with much fanfare. Along with this listing, changes to the prescribing requirements for taxanes also occurred.
Date:   Feb 2007

Title:   Listing of Herceptin on the PBS
Publisher:   Australian Government Department of Health and Ageing
Description:   The Government has accepted a recommendation from the Pharmaceutical Benefits Advisory Committee (PBAC) to list the drug trastuzumab (Herceptin®) on the Pharmaceutical Benefits Scheme (PBS).
Date:   Oct 2006

Title:   Cancer antibodies (Comment for consumers)
Publisher:   Australian Prescriber
Description:   To reduce side effects, new treatments are needed which will kill the cancer cells but not damage normal cells. One approach is to make antibodies against the cancer cells.
Date:   Dec 2003

Title:   Antineoplastic antibodies - clinical applications
Publisher:   Australian Prescriber
Description:   Trastuzumab and rituximab are genetically engineered antibodies which are now available for the treatment of metastatic breast cancer and non-Hodgkin's lymphoma respectively.
Date:   Dec 2003
Results 1 to 9 displayed.